Patient and Physician Perspectives on Mode of Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels-Reference-Cited by-同舟云学术

Patient and Physician Perspectives on Mode of Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels

Published:2015-09 Issue:9 Volume:37 Page:1945-1954.e6
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Roth Eli M.,Bujas-Bobanovic Maja,Louie Michael J.,Cariou Bertrand

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference16 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

2. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines;Stone;J Am Coll Cardiol,2014

3. Gitt AK, Ambegaonkar B, Brudi P, et al. Low LDL-cholesterol target achievement in statin-treated patients in clinical practice in China and Europe: results of the Dyslipidemia International Study (DYSIS). J Am Coll Cardiol. 2015;65(10_S):A1482.

4. Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status;Wong;Diab Vasc Dis Res,2013

5. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010);Wong;Am J Cardiol,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postmarketing Reports of Incomplete Dosing-Related Complications with Self-Injected PCSK9 Inhibitors: A Descriptive Study and Disproportionality Analysis;BioDrugs;2024-06-14

2. Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient reported outcomes;BMC Immunology;2024-02-20

3. Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions;Expert Opinion on Drug Delivery;2023-06-03

4. Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient-reported outcomes;2022-12-12

5. Perceptions of injectable therapies with cardiovascular benefit: an ACNAP survey of healthcare professionals to explore facilitators and barriers;European Journal of Cardiovascular Nursing;2021-11-24